Process for the production of piperidine derivatives with microorganisms

Details for Australian Patent Application No. 2001297767 (hide)

Owner AMR Technology, Inc.

Inventors Michels, Peter C.; Zirbes, Eric L.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001297767

PCT Number PCT/US01/43714

PCT Pub. Number WO2002/083062

Priority 09/708,959 08.11.00 US; 09/754,786 04.01.01 US

Filing date 6 November 2001

Wipo publication date 28 October 2002

Acceptance publication date 22 February 2007

International Classifications

C12P 17/12 (2006.01) Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms

C07D 211/46 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/70 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C12R 1/465 (2006.01)

Event Publications

2 January 2003 Complete Application Filed

  Priority application(s): 09/708,959 08.11.00 US; 09/754,786 04.01.01 US

17 April 2003 Application Open to Public Inspection

  Published as AU-B-2001297767

30 September 2004 Assignment before Grant

  Albany Molecular Research, Inc The application has been assigned to AMR Technology, Inc. 2002

22 February 2007 Application Accepted

  Published as AU-B-2001297767

21 June 2007 Standard Patent Sealed

30 July 2009 Assignment Registered

  AMR Technology, Inc. The patent has been assigned to Albany Molecular Research, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001297768-MODULATION OF GENE EXPRESSION IN MOUSE GENETIC MODELS OF ATHEROSCLEROSIS

2001297766-THE USE OF BETA 1,3 - GLUCAN - CONTAINING COMPOSITIONS TO POTENTIATE IMMUNE RESPONSES BY UPREGULATING THE EXPRESSION OF COSTIMULATORY MOLECULES